Valuation Provectus Biopharmaceuticals, Inc. OTC Bulletin Board

Stocks

End-of-day quote OTC Bulletin Board Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-

07-07	Provectus Biopharmaceuticals, Inc. Highlights Peer-Reviewed Study Demonstrating Opposing Mechanistic Effects Of Rose Bengal Sodium At The Same Dose	CI
06-25	Provectus Biopharmaceuticals, Inc. Launches Veripure Open Science Program For Medical Research Access To PV-10	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	23.43	23.07	45.43	40.27	50.48	23.49
Change	-	-1.55%	96.93%	-11.35%	25.33%	-53.46%
Enterprise Value (EV) ¹	47.13	24.13	47.59	43.22	53.35	26.22
Change	-	-48.8%	97.24%	-9.18%	23.43%	-50.85%
P/E	-3.44x	-4.05x	-12.8x	-13x	-10.6x	-4.33x
PBR	-0.77x	-5.48x	-7.27x	-5.29x	-8.45x	-3.72x
PEG	-	0.2x	0.3x	1x	-0.2x	-0.3x
Capitalization / Revenue	-	-	45,934,892x	72,213,378x	81,789,566x	69,899,095x
EV / Revenue	-	-	-	-	-	-
EV / EBITDA	-10x	-5.21x	-14.1x	-17.4x	-13.5x	-5.41x
EV / EBIT	-9.55x	-5.2x	-14x	-17.3x	-13.5x	-5.41x
EV / FCF	44.5x	-3.48x	-39.6x	-37.2x	-18.2x	-19.6x
FCF Yield	2.25%	-28.8%	-2.53%	-2.68%	-5.5%	-5.1%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-0.017	-0.0136	-0.008474	-0.007393	-0.0113	-0.0129
Distribution rate	-	-	-	-	-	-
Net sales	-	-	0.989	0.5577	0.6171	0.3361
EBITDA ¹	-4.694	-4.628	-3.38	-2.489	-3.939	-4.842
EBIT ¹	-4.936	-4.641	-3.391	-2.498	-3.946	-4.844
Net income ¹	-6.678	-5.54	-3.555	-3.102	-4.762	-5.431
Net Debt ¹	23.7	1.061	2.163	2.95	2.877	2.727
Reference price ²	0.0584	0.0550	0.1083	0.0960	0.1201	0.0559
Nbr of stocks (in thousands)	401,232	419,447	419,497	419,522	420,280	420,280
Announcement Date	3/2/21	3/29/22	3/30/23	3/28/24	3/28/25	3/26/26

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
WUXI APPTEC CO., LTD.	20.83x	6.36x	13.92x	1.53%	55.27B
ARGENX SE	32.72x	8.17x	25.61x	0.05%	54.15B
INSMED INCORPORATED	-41.75x	13.26x	-39.07x	-.--%	23.11B
BIONTECH SE	-18.34x	4.38x	-7.67x	-.--%	23.22B
WUXI BIOLOGICS (CAYMAN) INC.	25.44x	5.01x	13.23x	-.--%	20.33B
GENMAB A/S	24.96x	4.84x	15.73x	-.--%	17.91B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-612.56x	37.5x	-1557.05x	-.--%	15.76B
PHARMAESSENTIA CORPORATION	45.31x	18.35x	47.24x	0.08%	15B
EXELIXIS, INC.	17.3x	5.01x	11.68x	-.--%	13.82B
Average	-56.23x	11.43x	-164.04x	0.18%	26.51B
Weighted average by Cap.	-26.16x	9.75x	-92.41x	0.37%